Melanogenic Regulatory Factors in Coated Vesicles from Melanoma Cells  by Chakraborty, Ashok K. et al.
Melanogenic Regulatory Factors in Coated Vesicles 
from Melanoma Cells 
Ashok K. Chakraborty, Ph.D, Yutaka Mishima, M.D, Ph.D, Mizuho Inazu, Susumu Harta, M.D, and 
Masamitsu Ichihashi, M.D. ph.D. 
Department of Dermatology. Kobe University School of Medicine. Kobe, J ap.:m 
Coated vesicles have been found to contain much higher 
tyrosinase and y-glutamyl rranspeptidase activities than pre-
melanosomcs. This indicates that similar to tyrosinase. y-
glutamyl cranspepridasc, an enzyme responsible for pheome-
lanogenesis. is highly concentrated in coated vesicles after its 
maturation in Golgi associated endoplasmic reticulum 
(GERL). Furthermore. in the pre- and past-dapaquinane 
melanogenic pathway, coated vesicles convert dopachrome 
to colorless indole compounds more quickly than in premel-
anosomes because of rhru hjgher dopachrome conversion 
O riginal concepts of the iuitial stages of melanogen-esis tnvisioned the joining of active tyrosinase with premelanosomes in a specialized functional seg-ment of the Goigi apparatus (11. However. work from our laboratory has indicated that newly syn-
thesized tyrosinase is activated through glycosylation steps that 
occur along with other processing events in the GERL and coated 
vesicle (CV) system [2,31 and eventually lead to the formation of 
active melanin polymers in vivo [4.5]. We have also reported much 
higher tyrosinase activity in the GERL and CV than in the pre mel-
aDosome (PMS) fractions of the pigment cells [2]. Thus, the transfer 
of activated tyrosinase into PMS by CV is presumed to be necessary 
for the initiation of melanization in vivo, which can be observed by 
electron microscopy [6]. 
Another glycoprotein, y-glutamyl trans-peptidase (yGTP), an en-
zyme involved in pheomelanogenesis, has been shown to co-exist 
with tyrosinase in premelanosomes {7,8]. Our presem studies seem 
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Abbreviations: 
CV: coated Vesicle . 
DCF: dopachrome conversion facror 
DOC: dicthyl dithiocarbamate 
DHICA: 5,6-dihydroxy indole 2-carboxylic acid 
DOPA: 3.4-dihydraxy ph~nyl alanine 
GERL: galgi-associated endoplasmic reticulum of lysosome. 
IBF: indole blocking factor 
ICF: indole conversion factor 
IQ: indale-5 ,6 quinone 
MS: mel;lnosome 
PMS: premelanosome 
yGTP: y-giucamyl ttanspeptidast" 
factor activi ty. Melanosomes have been found to exhibit in-
dole conversion factor activiry. while coated vesjcles show 
indole blocking fac tor activity. In moderately tyrosinase-rich 
preme1anosomes. the levels of dopachrome convtrsion factor 
and indole blocking factor are lower than in coaced vesicles or 
meJanasames. H igh levels of indole blocking factor in coated 
vesicles may indicate why melan in polymer formation does 
not occur there in vivo despite their high tyrosinase activity.J 
[,mest DermatoI93:616-620, 1989 
to indicate thar GERL-CV is also involved with yGTP maturation 
and activation. In addition, we have found that other regulatory 
factors in melanogenesis, namely, dopachrome conversion factor 
(DCF), indole blocking factor (IBF), and indole conversion factor 
(ICF). first described by Pawelek and co-workers [9.10]. are present 
in higb specific activities in the CV system. The distribution of 
chese variousacriviries in various subcelJu1,ar fracrions from pig-
mented melanomas allows us to postulate mechanisms for the re-
S[cictlon of melanin formarion to melanosomes, and ro offer an 
explanation for the absence of mdanin in CV, despjr~ the presence 
of high tyrosinase activity [5]. 
MATERIALS AND METHODS 
Subcellular Fractionation Coated vesicles were isolated from 
BL-6 murine melanoma grown subcutaneously in nude mice 
(BALB/C, nu/ nu) and from Greene 's malignant melanoma main-
tained in the laboratory by serial transplantation into Syrian 
(Golden) hamSters. by the method of Usami et al [I I]. Briefly. the 
tissues were homogenized in t V of MES buffer (PH 6.5) containing 
0. 1 M MES (2-N-morpholino ethane sulfonic acid). 1 mM EGTA. 
0.5 mM MgCI2 ' and 0.02% sodium az ide. T he homogenate was 
centrifuged at 20,000 g for 30 min and the supernarenr was ag.ain 
centri fuged at 55,000 g for 60 min. The peller was suspended in 
MES buffer containing 10% sucrose. Coated vesicles were precipi-
tated by centrifugation for 60 min .n JOO,OOO g. The pellct was 
homogenized in a small volume of the buffer and underwent con-
tinuous 30%-50% sucrose density gradient ultracentrifugation for 
t 6 h at 50,000 g. A tu rbid hand ar abour 35%-40% sucrose was 
collected and diluted fourfold with the buffer and centrifuged at 
100,000 g for 60 min. The pellet was resuspended and again ultra-
cenrrlfuged in a continuous 5%-30% sucrose gradient for 60 min at 
100,000 g. A band at the density of about 14%-20% sucrose was 
collected, pooled. and precipitated by centrifugation. The purified 
CV were resuspended in a: M g+2 free MES buffer. 
Premelanosome (PMS) and melanosome (MS) subfractions were 
separated from [he 20,000 g pellet (large granule fraction) by su-
crose density gradient ulrr.:lcentrifug.ltion as described earlier ~12]. 
The so-called Goigi apparatus (G 2) and soluble fractions from 
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Greene's melanotic melanoma were isolated as described previously 
[3.12J. 
Electron Microscopic Study Isolated fractions were observed 
under an electron microscope by the technique of negative staining 
using a 1 % phosphotungstic acid sol ution. 
Tyrosinase Assay Tyrosinase was measured spectrophocometri-
cal ly by following production of dopachrome (DC,orange) from a 
soludon of 1.0 mM L-DOPA in a 3· ml reaction mixture containing 
0.2 M phosphate buffer (PH 6.8). Ac<ivity was expressed as tJ.F. j 
min/ mg protein as per Hamada and Mishjrna l13J. 
Y-GTP Assay }(;TP was measured according to Tate and Meister 
11 4]. T he reaction mUcture contains 0.1 ml cell homogenate, 0.9 ml 
substrate solution of 2.5 mM L-y-glutamyl-p-nitroanil ide, 20 mM 
glycyl glycine. 75 ruM NaCI. and 50 ruM Tris-HCI buffer (pH 8.0) 
an.d was in.cubated for 10 min a[ 37"C with constant stirring. T he 
reaction was terminated by the addition of 1.0 mJ of3 N acetic acid, 
and the absorbance of the p-nitro-anilide released was measured 
spectrophotometrically at 410 nm. The enzyme activity was ex-
pressed as dE/ l 0 minlmg protein. 
Protein Determination Protein was determined by Lowry's 
method using bovine serum albumin as standard [15]. 
Synthesis of Dopachrome (DC) Dopachrome was synthesized 
using the method of Korner and Pawelek [91 modified from the 
method of Mason [16J. Briefly. ice-cold dopa (0.5 mg per ml of 
0.1 M sodium phosphate buffer. pH 6.8) was mixed with Ag',):O 
(30 mg Ag,O: 1 mg dop') for about 1 min and filtered through a 
0.22-l'm millipnre filter. 
Dopachrome conversion factor (DCF) activity was measured 
spec(fophotometrically by the method of Korner and Pawelek [9]' 
The standard assay consisted of 0.5 rol DC solution and the extract 
of thl" fractions (0.2 mg protein) and 0.05 M sodium phosphate 
buffer (PH 6.8) in a total volume of 3 m!. The decrease in absorb-
ance at 475 nm was noted. Diethyl dithio carbamate (DOC) was 
used to block the tyrosinase interference in DCF assay. 
Indole Conversion Factor (ICF) and Indole Blocking Factor 
(lBF) Activity [1 0.17J The excract of CV and other organelles 
(0.2 mg protein) were mixed with 0.5 m1 DC solurion in a total 
volume of 3 ml containing 0.05 M phosphate buffer, pH 6.8. In-
creases in absorbance .It 540 nm with time due to melanin synthesis 
were observed chat could be readily detected visually. 
RESULTS 
Electron Microscopic Findings CV fractions consist almost ex-
clusively of coated vesicles thac appear as small spheroid bodies 
having a coated surface (Fig 1). Figures 2 and 3 show PMS and MS 
fractions, respectivdy. Thes~ fractions comain many ellipsoid 
bodies, which frequently reveal an oriented paral lel array of mem-
branes in the PMS fractions (Fig 2). 
Tyrosinase and yGTP of CV Coated vesicle fractions are not 
only rich in tyrosinase but also contain substantial amounts of yGTP 
(Figs 4 and 5). The high yGTP activity in CV fractions is also 
presumably due to the presence of the ectozyme portion of this 
enzyme. 
Dopachrome Conversion Factor (DCF) Activity Coated ves-
icle frac tions have higher DCF activity chan PMS (Fig 6). Their 
different DCF activity is clearly seen in the presence of tyrosinase 
inhibitors like DDC (lmg), which indicates that, unlike tyrosinase, 
DCF is unaffected by DDC and should be assayed in the absence of 
tyrosinase interference when the substrate still contains dopa. 
Indole Conversion Factor (ICP) and Indole Blocking Factor 
(mF) Activity Melanin formation from dopachrome is inhibited 
in {he presence of CV, whereas an increase in indole conversion 
ability to melanin is observed in MS. PMS show some blocking 
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Figure 1. Electron micrograph of coated vesicle fractions. It contains nu-
merous spheroid bodies that exhibit coated surface Structure. Negative stain 
with 1% phosphotungstic acid (X24,150) . 
factor activity but much less than that of CV (Fig 7). After 40-min 
incubation, a rise of only 25% in absorbance was observed at 540 nm 
in the presence of CV whereas rises of 90%, 160%, and 210% were 
noted in the presence of PMS, buffer (control). and MS, respec-
tively. It appears, therefore, that during differentiation of melano-
somes from CV through PMS, a gradual increase in indole conver-
sion ability to melanin appears at the expense of indole blocking 
factor activity. Studies with Greene's melanotic melanoma also 
show similar results in the 3ctiviry of these factors within subcellu-
lar fractions (Table l). 
DISCUSSION 
In the recent concept of mixed melanogenesis, while tyrosinase is 
involved in both eumelanin and pheomelanin formation, anothr:t 
enzyme, yGTP. glycoprotein in nature [18], plays the essential role 
in phcomelanogenesis {7,19J. Previously, it. was reponed that pre-
melanosomes are not only rich in tyrosinase but also contain sub-
Figure 2. Elc:ctron microguph of premeianosorne fraction. It contains an 
oriented p.:lraJlei array of membranes. Negative stain with 1 % phosphotung-
stic aci.d (X 21 ,OOO). 
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Figure 3. EIC'ctron microgr.r.ph of mdanosome rich fractions. it contains 
num~rous ellipsoid bodies which appear uniformly d~nse . Negative stain 
with 1% phosphotungstic lIcid (><21,000). 
scamial amOunts of yGTP [8]. In the present study we have shown 
that CV also contain high ryrosinase as well as yGTP activity (Fig 
4) . Compared with the other subcel lular fracrions, it becomes obvi-
ous thar ryrosin.::asc-rich CV fracrions contain the high est yGTP 
activity among the so-called golgi fractions, prcmelanosomes, and 
soluble fractions (Fig 5). These findings seem to indicate that, simi-
lar to the tyrosinase maruration process, yGTP synthesized by ribo-
somes is glycosylated and concentrated in GERL and then trans-
ferred to PMS presumably by CV. As far as we know. this is the first 
report of a possible function of coated vesicles in the initiation of 
phcomelanogenesis as well as eumelanogenesis in vivo. 
Reccnr studies on melanin biosynthesis as a polymerization have 
shown that the process distal to the tyrosinase action sites is not 
spontaneous but under some regulatory comrol: "dopachrome con-
version factor (DCF) ," which promotes the con version of do-
pachrome (DC) to 5.6-dihydro,xy indole 2-carboxylic acid 
(DHICA) [9J; "indole blocking factor (IBF)." which inhibits the 
con'l;crsion of DC [0 indole ,]uinone (IQ); and " indole conversion 
factor (ICF)," which promotes the conversion of DC to IQ through 
colorless indole derivatives 19,1 OJ . The activity of the indole con-
TYROSINASE AND r-GTPASE Activity in c oated vesicle 
f raction of Melanoma 
Relatl ... e spec ific actiVity [ _~1Ho11 ""1.0 Relative speCific activit..,. 
160 100 28.0 20.0 12.0 4.0 4.0 12. 0 20.0 28.0 
-1- ; •• l ·;·: : 
160 100 28.0 20.0 12.0 4.0 4. 0 12.0 20.0 28.0 
T YI"05;"858 T-Glutarnyl Tran5j)eptidase 
. " .. .. -ElI II 1. 2. 3 • • from Gt_ .... 1.tn<>1.e __ 
• _E~II 5 f rom BL-6 ...... ' ... meIa_ 
Fi.gure • . Tyrosin.:asc and yGTP activity in CV fractions of melanom.:a. 
Their specifi c activities relan ve to homogenate (= 1.0) h.:ave been presented. 
Experiments 1,2.3. <lind 4. respectively from Greene'!; melanotic melanoma. 
and experiment 5 from BL-6 murine melanoma. 
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Figure 5. Comparison of tyrosinas(: and yGTP activiry of C V with other 
subcellular fractions from Green(:'s melanotic melanoma. 
version facror can be partially accounted for as melanosomal tyro-
si nase [17.201. King e t al reported that DCF and indole blocking 
f~ctor acriviry is due ro a new e-nzyme. Mr. of34,OOO. w hich is heat 
labile , protease sensitive, and not inhibited by tyrosinase inhibitor, 
DOC \21]. T hey have also shown that subcellular distribution of 
this new enzyme is simi lar to that of tyrosinase among microsomal , 
melanosomal, and soluble fr3ct.ions in D-16 melanoma. Hearillg et 
al. on the other hand, reported the association of indole blocking 
factor activity with non-membrane bound cyrosinases. whiJe [he 
membrane-bound tyrosinase is associated with the activity that ac-
ccJerares mcJanin forma t jon from DC 122}. 
0.2 
o 
Dopachrome Conversion Factor activity of 
BL-6 melanotic melanoma subfractions. 
• 
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Time (min) 
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Figure 6. Dopachrome conversion (;acto r activity of cou ed ves icle. pre· 
mehmosome, and melanosome fractions from BJ.....6 melanoma. Freshly pre-
pllre:d dopachromc solution (O.5ml) W~ incubated with the extract , as indi-
cated in the fig ure in a total volume of 3 ml at pH 6.8 and 37°e. The 
decrease in absorbance due to conversion of dopachrome to colo rless indole 
deriv:ui v(' was noted . The experiments were repeated several times with 
similar results each time. 
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Indole Conversion Factor and Indole Blocking 
Factor activity in BL -6 melanoma subfractions. 
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Figure 7. Indole COTlversion factor and indole blocking factor activity in 
HL·6 melanoma subfracoolls. Oopachrome solution (fresh), 0.5 ml was in· 
cubated with the extracts :u pH 6.8 and absorbance was noted at 540 nm 
with dme. The increase in absorbance at 540 nm was due to melanin synthe. 
sis which could be detected visually. The initial decrease was due to DCF 
3ctiviry becau$(' dopachrome shows some of its :absorbance at 540 nm. The 
higher vaJ ue over buffer (control) represents JC F activity and the re .. erse 
reprcsc:.nts the: activity of lBF. The eXJXriments were repeated several tim(':j, 
with similar results each rime. 
However, intracel lular JocaJization of these factors (DCF, IC F, 
and lBF). in reference to various functionally diifercmiatcd mela· 
nogen ic comparnnel1ts, has not been clarined yet. 
The- presem study shows that DCF activity in CV fractions is 
significantly higher than PMS when tyrosinase activity is blocked 
by DDC during DCF assay (Fig 6). MS fraccions hay. no DCF 
activity . These results are in ::tgreement with the observation of 
King et al !21J tbat DCF is d itl"erent from ryrosinase and seem to 
Table I. Dopachromc Conversion Factor (DCF), Indole 
Conversion Factor, (IC F) and (ndole Blocking 
Factor (IBF) Activity in Subcellular Fractions from 
Greene's Melanotic MeI:momaa 
Perc~ntage of activity 
Fractions DCF ICF IBF 
e v (0.2 mg protein) 87.5% 8.4% 91.6% 
PMS (0.2 mg protein) 25.0% 57.7% 42.3% 
MS (0.2 mg protein) N.D" 137.8% 
Buffer control .... 100% 
• Oopathtomt: conversion in praencc of buffet ~ftet 20 min. of ineul».tmn .... ·ltb 
dop:achromC' (as describW in M4~ri41J dnJ MuhoJJ) is coru ide~ 100% (control). DCF 
xtivity of the' subcellular fractions was calcubu:d :IS thc differcnCe' of pc'~ntagc of 
do~ch romC' convcrsion in 20 min. from buffer (control). Indolc blocking .flCt?f 
:ilC:tivlf)' - Indok conversion in prcse-nce- or buffct (comroJ) - Indole convenlon In 
presence of nmpb after 40 min. incubation with dop.achrome as described in Mattrials 
4nJ Mefhods. 
\> N .D: Not deI.CCI"aOle. 
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indicate that in CV. dopa conversion to dopachrome and thereafter 
to colorless indole compound takes place more quickly chan in PMS 
because of higher tyrosinase and DCF activity in C V. Moreover. 
CV show indole blocking factor act ivity, while MS exhibit indole 
conversion faccor (Fig 7). Premelanosomes are observed to exhibit 
only moderate LBF activity. Therefore, it is rational to assume that 
during the process of differentiation of melanosom.es tbac occurs 
through sequen tial stages of development ofPMS (stage I. scage II) 
(23J. the blocking f.actor may lose iu activity. and thus indole con-
version ability gradually appears. 
We have previously shown that the CV isolated from melanoma 
cont.ain primarily the membrane bound tyrosinase, T). in addition 
to T. , whereas the melanosomal fraction of these pigment cells 
contains T 3 only [24.25). Hearing et al (22) have recendy reported 
differential functions of multiple forms of tyrosinase in [he melano-
gen~sis pathway. It was shown that sol uble tyrosinase (T 1) con tains 
indole blocking fac tor activity, while membrane-bound tyrosinase 
(T 3) accelerates melanin fonnation from dopacbrome. 
Our present findings combined with previous reports indicate 
[hat during (he process of maturation of tyrosinase. which seems to 
proceed from T 2 to T 1 and then to T 3 with sequential changes in 
carbohydrate moicties as ryrosinase is transferred from ribosome to 
PMS through such melanogenic compartments as GERL and CV 
12]. the: blocking [;Ictor may either become in2ctivat~d Or trans-
formed to JC F. 
He'nce. we can conclude from our presem results that 1) DCF is 
different from tyrosinase as well as from indole blocking factor. 2) 
CV have high DCF that converts DC to colorless indole com-
pound, 3) MS have only ICF activity . whereas in moderately tyro-
sinase-rich PMS, levels of DC F and lBF activity are lower than in 
CV or MS. and 4) changes ofT. (om) to T) may be associated with 
changes of indole- blocking activity to indole conversion activity. 
Last, the presence' of high DCF and indole blocking factor activ-
ity in CV clearly indicates why melan.ization does om occur there in 
vivo, even though CV contain high tyrosinase activity. 
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